For years, STORZ MEDICAL has been teaming up with medical specialists to pioneer the development of radial shock wave transmitters, which are used to treat myofascial conditions. One of the challenges that medical professionals face every day when using shock waves is ensuring that treatment of particularly sensitive and deep-lying trigger points and myofascial imbalances is gentle, effective and virtually pain-free.
In 2018, Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«. TPS was developed by STORZ MEDICAL in collaboration with a team of researchers from the Medical University of Vienna (Department of Neurology), led by Professor Roland Beisteiner, and Dr. Henning Lohse-Busch, Rheintalklinik, Bad Krozingen. In December 2019, the prestigious journal »Advanced Science« published a study, in which Beisteiner et al. evaluate the method and present first treatment results. The presented data shows that it is possible to improve brain performance with TPS and that there is a long-term effect.
Düsseldorf/Germany: After three fascinating and very interesting days, MEDICA 2019 ended on 21 November. Once again, the world’s leading medical trade fair was a huge success. At STORZ MEDICAL’s exhibition stand in hall 10, the full range of the company’s therapy options was on display – including several innovations. Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system, a unique procedure for patients with Alzheimer's disease, was explained in detail by Dr Rafael Storz, who also answered the visitors’ questions. In addition, the new MAGNETOLITH® for Extracorporeal Magnetotransduction Therapy (EMTT®) and the redesigned MODULITH® SLC were also at the centre of attention. Both devices were unveiled and presented during the trade fair.
On 1 September 2019, STORZ MEDICAL celebrated the opening of STORZ MEDICAL France, which is managed by Mihai Atanasiu. With the new office in Paris, STORZ MEDICAL wants to meet the needs of its customers in this important market for shock wave devices in the best possible way in the future. The goal is to create the conditions for even greater customer proximity by providing direct selling and equipment service/support. The new office is STORZ MEDICAL’s fifth office outside of Switzerland. The other offices are in Germany (Jena), Italy (Rome), Spain (Barcelona) and UK (London).
The »Christian Chaussy Award« is a new award launched by the German Society for Shock Wave Lithotripsy (DGSWL) to recognise outstanding scientific work. STORZ MEDICAL supports the award with a research grant, the prize money is €2,500. It was presented for the first time during the 71st Congress of the German Society of Urology (DGU) in Hamburg, Germany, on 18 September 2019.